A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

Clinical trial NCT07444450 · RECRUITING

Trial details

NCT number: NCT07444450
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Atrophy, Spinal

Start date: 2026-09-04
Primary completion: 2029-07-27
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.